Trials / NCT00345917
Safety Study in Retinal Transplantation for Retinitis Pigmentosa.
Completed Phase 2 Device
- Sponsor
- Radtke, Norman D., M.D.
- Treatment
- Retinal transplantation instrument; Fetal tissue.
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa.
- Ages
- 21 Years to no upper limit
- Enrollment
- 10 participants
- Started
- 2002-02
- Main results expected
- 2012-03
- Results posted
- Not yet
- Record last updated
- 2012-04-11
What the study is testing
The long-term goal is to show that retinal transplantation can help to prevent blindness and to restore eyesight in patients with the inherited disease retinitis pigmentosa.
Where it runs
United States (1)
- Retina Vitreous Resource Center, Louisville, Kentucky